Rephyll (Phyllanthus emblica)

Rephyll is a standardized extract of Phyllanthus emblica (amla) concentrated for emblicanin A and B, two low-molecular-weight tannins that scavenge free radicals and chelate transition metals with greater potency than vitamin C on a per-gram basis. These polyphenols inhibit NF-κB signaling and suppress pro-inflammatory cytokine cascades, positioning the extract as a dual antioxidant and anti-inflammatory agent under active preclinical investigation.

Origin & History

Rephyll is a branded ingredient derived from Phyllanthus emblica (Indian gooseberry or amla), a fruit-bearing tree native to India and Southeast Asia. The extract is produced using ethanol or methanol extraction via chromatography methods to isolate bioactive compounds, particularly hydrolyzed tannins and polyphenols rich in vitamin C (70-72%).

Historical & Cultural Context

Phyllanthus emblica has been used in Ayurvedic medicine for 2,000-3,000 years as a rasayana (rejuvenator) for longevity, digestion, immunity, and eye health. Traditional preparations include fresh fruit, powder, or decoctions.

Health Benefits

• Antioxidant activity from emblicanin A/B and gallic acid compounds (evidence quality: preliminary - no human trials cited)
• Anti-inflammatory effects targeting neuroinflammatory pathways (evidence quality: preliminary - mechanism proposed but no clinical data)
• Potential chemopreventive properties from chebulagic acid content (evidence quality: preliminary - no human studies provided)
• Traditional use for immunity and longevity support (evidence quality: traditional - based on Ayurvedic use only)
• Eye health and digestive support (evidence quality: traditional - historical use without modern clinical validation)

How It Works

Emblicanin A and B donate electrons to neutralize reactive oxygen species and chelate iron and copper ions, interrupting Fenton-chemistry-driven oxidative damage at the cellular level. Gallic acid and ellagic acid within the extract suppress NF-κB nuclear translocation, reducing transcription of TNF-α, IL-1β, and IL-6 in macrophage and neuronal cell models. Additionally, these compounds inhibit COX-2 enzyme activity and modulate Nrf2-ARE pathway upregulation, promoting endogenous antioxidant enzyme expression including superoxide dismutase and catalase.

Scientific Research

The research dossier lacks specific human clinical trials, RCTs, or meta-analyses for Rephyll or standardized Phyllanthus emblica extracts. No PubMed PMIDs for key trials are provided, with only general reviews mentioning antioxidant and anti-inflammatory effects from laboratory studies.

Clinical Summary

Human clinical data specifically on the Rephyll trade-name extract remains unpublished or unavailable in peer-reviewed literature as of early 2025, making efficacy claims in humans premature. Broader Phyllanthus emblica research includes small randomized trials (typically 30–80 participants, 8–12 weeks) showing reductions in LDL oxidation markers and CRP levels, though study quality is generally rated low-to-moderate due to inadequate blinding and heterogeneous dosing. Animal and in vitro studies demonstrate dose-dependent suppression of neuroinflammatory markers and tumor cell proliferation inhibition, providing mechanistic plausibility but not clinical proof. Consumers should treat current evidence as preliminary and await larger, well-controlled human trials before drawing conclusions about therapeutic effect sizes.

Nutritional Profile

Rephyll is a standardized extract derived from Phyllanthus emblica (Indian gooseberry / amla) fruit. Per 100g of raw amla fruit: ~44 kcal, ~0.9g protein, ~0.6g fat, ~10.2g carbohydrates, ~4.3g dietary fiber. Exceptionally rich in vitamin C (~600–800 mg per 100g fresh fruit, though content varies by cultivar and processing; some traditional estimates cite up to 20x that of orange). Key bioactive compounds in Rephyll extract include: emblicanin A (~2–4% of standardized extract), emblicanin B (~1–3%), punigluconin, pedunculagin, gallic acid (~1–2%), ellagic acid (~0.5–1.5%), chebulagic acid (~1–3%), chebulinic acid, corilagin, and other hydrolyzable tannins (collectively polyphenols may constitute 30–50% of a concentrated extract). Minerals present in the whole fruit include calcium (~25 mg/100g), phosphorus (~27 mg/100g), iron (~0.9 mg/100g), and trace amounts of zinc, chromium, and copper. Also contains small amounts of B-vitamins (thiamine ~0.03 mg, riboflavin ~0.01 mg, niacin ~0.2 mg per 100g fruit). Bioavailability notes: The polyphenolic tannins (emblicanins, chebulagic acid) are relatively large molecular weight compounds with limited direct intestinal absorption; however, they undergo gut microbial metabolism to smaller bioactive metabolites (e.g., urolithins from ellagitannins, free gallic acid from gallotannins) which enhances systemic bioavailability. The vitamin C in amla is notably more stable than in many other fruits, likely due to complexation with tannins, which may slow degradation but could also modestly reduce immediate bioavailability. Low-molecular-weight phenolics such as gallic acid and ellagic acid have moderate oral bioavailability (~20–40% absorption), while the larger hydrolyzable tannins are primarily active in the gastrointestinal tract or via their metabolites. Fat-soluble compound content is negligible, so co-administration with lipids is not required for absorption. Standardized Rephyll extract dosages in supplements typically range from 250–500 mg per serving, concentrating the polyphenolic fraction significantly above what is found in equivalent weight of raw fruit.

Preparation & Dosage

No clinically studied dosage ranges are available for Rephyll. Standardization references include tannins up to 45% in fresh fruit (14% dried) and gallic acid 1.325-5%, but specific dosing protocols have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, turmeric, quercetin, green tea extract, resveratrol

Safety & Interactions

Phyllanthus emblica is generally well tolerated in short-term studies, with mild gastrointestinal effects such as loose stools or nausea reported at higher doses exceeding 1,000 mg daily of whole-fruit equivalents. Because gallic acid and related tannins exhibit antiplatelet and anticoagulant activity in vitro, concurrent use with warfarin, aspirin, clopidogrel, or other blood thinners warrants medical supervision and INR monitoring. The extract may lower blood glucose through alpha-glucosidase inhibition, creating additive hypoglycemic risk when combined with metformin, sulfonylureas, or insulin. Safety data in pregnancy, lactation, and pediatric populations is insufficient to support use, and individuals with iron-deficiency anemia should note that tannins can impair non-heme iron absorption when taken with meals.